birth control semaglutide effects on GLP-1s can affect oral control… (yes, you read that right Semaglutide & Birth Control: Safety,

Saxenda 3 mg daily for weight management): Proven efficacy with 5-8% weight reduction and cardiovascular outcome benefits in the LEADER trial Dulaglutide (Trulicity 0.75-4.5 mg weekly): Convenient once-weekly dosing with demonstrated cardiovascular benefit in the REWIND trial Tirzepatide (Mounjaro for diabetes

Your clinician can advise based on your individual circumstances

The Journal of Neuroscience, 24, 27972805

Gene Expression Profiles of Lesions In a previous study (Heard et al., 2016), we showed that the numbers of ectopic lesions established from endometrium lacking the progesterone receptor co-regulator KLF9 gene were increased in HFD-fed recipients, coincident with major changes in their molecular profiles